Rational Improvement of the Affinity and Selectivity of Integrin Binding of Grafted Lasso Peptides

Journal of Medicinal Chemistry
2014.0

Abstract

Integrins moderate diverse important functions in the human body and are promising targets in cancer therapy. Hence, the selective inhibition of specific integrins is of great medicinal interest. Here, we report the optimization of a grafted lasso peptide, yielding MccJ25(RGDF), which is a highly potent and selective αvβ3 integrin inhibitor. Furthermore, its NMR structure was elucidated and employed in a molecular dynamics approach, revealing information about the integrin binding mode and selectivity profile of MccJ25(RGDF).

Knowledge Graph

Similar Paper

Rational Improvement of the Affinity and Selectivity of Integrin Binding of Grafted Lasso Peptides
Journal of Medicinal Chemistry 2014.0
Nonpeptide αvβ3 antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide
Bioorganic & Medicinal Chemistry Letters 2002.0
Multiple N-Methylation by a Designed Approach Enhances Receptor Selectivity
Journal of Medicinal Chemistry 2007.0
Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery
Bioorganic & Medicinal Chemistry 2016.0
Synthesis and Biological Evaluation (in Vitro and in Vivo) of Cyclic Arginine–Glycine–Aspartate (RGD) Peptidomimetic–Paclitaxel Conjugates Targeting Integrin α<sub>V</sub>β<sub>3</sub>
Journal of Medicinal Chemistry 2012.0
Small Molecule Designed to Target Metal Binding Site in the α2I Domain Inhibits Integrin Function
Journal of Medicinal Chemistry 2007.0
Cyclization of RGD Peptides by Suzuki–Miyaura Cross-Coupling
Journal of Medicinal Chemistry 2019.0
Determination of the Binding Specificity of an Integral Membrane Protein by Saturation Transfer Difference NMR:  RGD Peptide Ligands Binding to Integrin α<sub>IIb</sub>β<sub>3</sub>
Journal of Medicinal Chemistry 2001.0
Synthesis and Biological Evaluation of Dimeric RGD Peptide−Paclitaxel Conjugate as a Model for Integrin-Targeted Drug Delivery
Journal of Medicinal Chemistry 2005.0
Discovery of Cyclic Peptidomimetic Ligands Targeting the Extracellular Domain of EGFR
Journal of Medicinal Chemistry 2021.0